Signup Crypto ETF Stocks News

Immatics Announces Full Year 2024 Financial Results and Business Update

Houston, Texas and Tuebingen, Germany, March 27, 2025 - Immatics N.V. ( NASDAQ: IMTX, "Immatics" or the "Company" ) , a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, today provided a business update and reported ...

Source: www.globenewswire.com
March 27, 2025 | 11:00:00
Category: News

Hudbay Consolidates 100% Ownership in its Copper Mountain Mine

TORONTO, March 27, 2025 ( GLOBE NEWSWIRE ) -- Hudbay Minerals Inc. ( "Hudbay" or the "company" ) ( TSX, NYSE: HBM ) is pleased to announce that it has entered into an agreement with Mitsubishi Materials Corporation ( "MMC" ) to acquire MMC's 25% interest in Copper Mountain Mine ( BC ) Ltd. ( ...

Source: www.globenewswire.com
March 27, 2025 | 11:00:00
Category: News

BeyondSpring Files 2024 Annual Report on Form 10-K

FLORHAM PARK, N.J., March 27, 2025 ( GLOBE NEWSWIRE ) -- BeyondSpring Inc. ( NASDAQ: BYSI ) ( "BeyondSpring" or the "Company" ) , a global clinical-stage biopharmaceutical company developing innovative cancer therapies, today announced that it has filed its annual report on Form 10-K for the ...

Source: www.globenewswire.com
March 27, 2025 | 11:05:00
Category: News

AKVA group ASA: Sale of shares in Abyss Group to Arcus Infrastructure Partners

Reference is made to the stock exchange notice on 12 March 2025 where AKVA group ASA ( "AKVA" ) announced the sale of its 21,55% ownership in Abyss Group AS to Arcus Infrastructure Partners LLP.

Source: www.globenewswire.com
March 27, 2025 | 11:10:00
Category: News

EDAP Reports Record HIFU Fourth Quarter and Full-Year 2024 Results

• Record full-year 2024 HIFU revenue of USD 25.7 million, an increase of 15.3% over full-year 2023 • Record Q4 2024 HIFU revenue of USD 9.3 million, an increase of 15.0% over Q4 2023 • U.S.

Source: www.globenewswire.com
March 27, 2025 | 11:10:00
Category: News

Alterity Therapeutics Completes Last Patient Visit in ATH434-202 Open-Label Phase 2 Trial in Multiple System Atrophy

- ATH434 is a Disease Modifying Drug Candidate Targeting Parkinsonian Disorders ...

Source: www.globenewswire.com
March 27, 2025 | 11:25:00
Category: News

The Zacks Analyst Blog Highlights Alphabet, MicroSectors Gold Miners 3X Leveraged ETN, Direxion Daily FTSE China Bull 3X Shares, Direxion Daily FTSE Europe Bull 3x Shares, Direxion Daily MSCI Mexico Bull 3X Shares and Direxion Daily Aerospace & Defen

Alphabet, MicroSectors Gold Miners 3X Leveraged ETN, Direxion Daily FTSE China Bull 3X Shares, Direxion Daily FTSE Europe Bull 3x Shares, Direxion Daily MSCI Mexico Bull 3X Shares and Direxion Daily Aerospace & Defense Bull 3X Shares are included in this Analyst Blog.

Source: www.zacks.com
March 27, 2025 | 09:00:00
Category: News

The Zacks Analyst Blog Highlights Synchrony Financial, Target, American Express, Capital One Financial

Synchrony Financial, Target, American Express, Capital One Financial are included in this Analyst Blog.

Source: www.zacks.com
March 27, 2025 | 09:00:00
Category: News

The Zacks Analyst Blog Highlights Tesla, The Home Depot, Boston Scientific, Frequency Electronics and Bridger Aerospace

Tesla, The Home Depot, Boston Scientific, Frequency Electronics and Bridger Aerospace are included in this Analyst Blog.

Source: www.zacks.com
March 27, 2025 | 09:00:00
Category: News

Zacks Investment Ideas feature highlights: Verizon, Apple and NVIDIA

Verizon, Apple and NVIDIA have been highlighted in this Investment Ideas article.

Source: www.zacks.com
March 27, 2025 | 09:00:00
Category: News

© Natavest 2025 - 2026